Ulrike Gnad-Vogt
Corporate Officer/Principal bei CUREVAC N.V.
Aktive Positionen von Ulrike Gnad-Vogt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 01.01.2019 | - |
| Chief Tech/Sci/R&D Officer | 01.01.2011 | 01.01.2019 | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 01.01.2011 | - |
Karriereverlauf von Ulrike Gnad-Vogt
Ausbildung von Ulrike Gnad-Vogt
| Universität des Saarlandes | Doctorate Degree |
Statistik
International
| Deutschland | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Börse
- Insiders
- Ulrike Gnad-Vogt
- Erfahrung
